Targeting the premetastatic niche: epigenetic therapies in the spotlight is a research paper published in Signal Transduction and Targeted Therapy (2020). On theSindex it has a DataRank of 0.385. It has been cited 12 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.385
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →Susan G. Komen
Grant: PDF17481555
U.S. Department of Health & Human Services | National Institutes of Health
Grant: K99CA218686
U.S. Department of Health & Human Services | National Institutes of Health
Grant: RO1CA46595
U.S. Department of Health & Human Services | National Institutes of Health
Grant: RO3CA212562
NIGMS NIH HHS
Grant: R01 GM051405
NCI NIH HHS
Grant: R01 CA046595
NCI NIH HHS
Grant: R03 CA212562
National Institutes of Health
Grant: 1R03CA212562-01
The role of CAF-1 complex in tumor progression
National Institutes of Health
Grant: 2R01GM051405-13
Signal Transduction to p70 S6 Kinase 1
National Institutes of Health
Grant: 5R01CA046595-14
MITOGENIC AND ONCOGENIC REGULATION OF ERK/RSK SIGNALING
National Institutes of Health
Grant: 1K99CA218686-01
Propionate metabolism as an essential metabolic adaptation for tumor progression
U.S. Department of Health & Human Services | National Institutes of Health
FWCI
0.45
Citation Percentile
0.6%
Citation Trend
Fields of Study
MeSH Terms
Keywords